Exercise Periodization and Older Adults

Aging Clinical Trial

Official title:

Effects of Resistance Training Periodization on Hemodynamic, Morphofunctional and Cognitive Parameters of Robust Older Women.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03443375
• Other study ID #: 835.733
• Status: Completed
• Phase: N/A
• First received: February 8, 2018
• Last updated: February 16, 2018
• Start date: January 2015
• Est. completion date: December 2015

Study information

• Verified date: February 2018
• Source: University of Campinas, Brazil
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The present study aimed at investigating the effects of two different resistance training protocols — nonperiodized (NP) and daily undulating periodization (DUP) — on hemodynamic, morphofunctional and cognitive parameters of robust older women. Methods: Forty-two older women were randomized allocated into one of the three experimental groups: NP, DUP, and control group (CG). Evaluations of the hemodynamic, morphofunctional and cognitive parameters occurred before, during and after six months. The exercise groups performed the program of exercise twice a week over 22 weeks. In NP, the two weekly sessions were based on 3 sets of 8-10 repetitions at a difficult intensity. However, in DUP, a power exercise session based on 3 sets of 8-10 repetitions at a moderate intensity was added in the first session of the week.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Aged =60 years;

• Female;

• Not having been part of a systematic program of physical exercises in the last 6 months;

• MEEM score >19 points;

• Kihon checklist score >10 points;

• Capacity to perform the basic and instrumental activities of daily living according to Katz and Pfeffer indexes;

• Self-reported good memory;

• Complete all measurements.

Exclusion Criteria:

• Changes on antihypertensive medication in the past 6 months prior to inclusion in the study;

• Cardiovascular disease (i.e., acute myocardial infarction, stroke, peripheral arterial disease, and transient ischemic disease)

• Metabolic disease (i.e., diabetes mellitus type I or II), pulmonary disease (i.e., emphysema)

• Neurological and/or psychiatric disease (i.e., Parkinson's or Alzheimer's disease)

• Skeletal muscle disorders

• Comorbidities associated with greater risk of falls

• Recent history of smoking or alcohol abuse

• Hormone replacement therapy and/or psychotropic drugs.

Related Conditions & MeSH terms

• Aging
• Blood Pressure
• Cognitive Decline
• Cognitive Dysfunction
• Physical Activity
• Physical Disability
• Sarcopenia

Intervention

Other:
• Physical exercise
The interventions proposed in the present trial were based on a safe and well-established exercise training program

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Campinas, Brazil

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in transfer capacity in seconds	TUG performance	6 months
Secondary	Changes in fat-free mass in kg	Fat-free mass	6 months
Secondary	Changes in overall cognitive capacity in points	MEEM	6 months
Secondary	Changes in blood pressure in mmHg	Blood Pressure	6 months
Secondary	Changes in shor-term memory in points	Memory	6 months